MedTrace Logo

Inflammation After Laparoscopic Robot-assisted Surgery for Locally Advanced Rectal Cancer

NCT04324567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2023-04-03

No results posted yet for this study

Summary

The intention of the study is to explore metabolic and inflammatory parameters in the pelvis and systemically after abdominoperineal resection (APR) for locally advanced rectal cancer (LARC) in patients that have received radiation therapy before surgery. In this study the inflammatory response after laparoscopic robot-assisted APR for LARC will be compared to results obtained in a recent cohort of patients operated with open APR for LARC, which will serve as the control population.

Conditions

  • Locally Advanced Rectal Cancer
  • Abdominoperineal Resection

Sponsors & Collaborators

  • University of Oslo

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Ebbe B Thorgersen, MD PhD · Surgeon, The Department of Gastroenterological Surgery, The Norwegian Radium Hospital, Oslo University Hospital

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-09
Primary Completion
2022-03-05
Completion
2022-03-05

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04324567 on ClinicalTrials.gov